175 related articles for article (PubMed ID: 12499061)
1. Staging of non-small cell lung cancer: imaging of intrathoracic disease.
MacDonald SL; Hansell DM
Eur J Radiol; 2003 Jan; 45(1):18-30. PubMed ID: 12499061
[TBL] [Abstract][Full Text] [Related]
2. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
3. The impact of fluorodeoxyglucose F 18 positron-emission tomography on the surgical staging of non-small cell lung cancer.
Vesselle H; Pugsley JM; Vallières E; Wood DE
J Thorac Cardiovasc Surg; 2002 Sep; 124(3):511-9. PubMed ID: 12202868
[TBL] [Abstract][Full Text] [Related]
4. Lymph node staging in lung cancer using [18F]FDG-PET.
Halter G; Buck AK; Schirrmeister H; Aksoy E; Liewald F; Glatting G; Neumaier B; Mühling B; Nüssle-Kügele K; Hetzel M; Sunder-Plassmann L; Reske SN
Thorac Cardiovasc Surg; 2004 Apr; 52(2):96-101. PubMed ID: 15103582
[TBL] [Abstract][Full Text] [Related]
5. Lung cancer staging.
Sihoe AD; Yim AP
J Surg Res; 2004 Mar; 117(1):92-106. PubMed ID: 15013719
[TBL] [Abstract][Full Text] [Related]
6. Staging intrathoracic non-small-cell lung cancer.
Hanson JA; Armstrong P
Eur Radiol; 1997; 7(2):161-72. PubMed ID: 9038108
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the diagnostic value of (18)F-FDG PET-CT and enhanced CT for staging of lymph node metastasis in non-small cell lung cancer].
Yang WF; Tan GZ; Fu Z; Yu JM
Zhonghua Zhong Liu Za Zhi; 2009 Dec; 31(12):925-8. PubMed ID: 20193335
[TBL] [Abstract][Full Text] [Related]
8. Endobronchial ultrasonography for positron emission tomography and computed tomography-negative lymph node staging in non-small cell lung cancer.
Shingyoji M; Nakajima T; Yoshino M; Yoshida Y; Ashinuma H; Itakura M; Tatsumi K; Iizasa T
Ann Thorac Surg; 2014 Nov; 98(5):1762-7. PubMed ID: 25149044
[TBL] [Abstract][Full Text] [Related]
9. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small cell lung cancer: a prospective analysis of 50 cases. Leuven Lung Cancer Group.
Vansteenkiste JF; Stroobants SG; De Leyn PR; Dupont PJ; Verschakelen JA; Nackaerts KL; Mortelmans LA
Chest; 1997 Dec; 112(6):1480-6. PubMed ID: 9404742
[TBL] [Abstract][Full Text] [Related]
10. Imaging of mediastinal lymph nodes: CT, MR, and FDG PET.
Boiselle PM; Patz EF; Vining DJ; Weissleder R; Shepard JA; McLoud TC
Radiographics; 1998; 18(5):1061-9. PubMed ID: 9747607
[TBL] [Abstract][Full Text] [Related]
11. Diffusion-weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results.
Nomori H; Mori T; Ikeda K; Kawanaka K; Shiraishi S; Katahira K; Yamashita Y
J Thorac Cardiovasc Surg; 2008 Apr; 135(4):816-22. PubMed ID: 18374761
[TBL] [Abstract][Full Text] [Related]
12. [Positron emission tomography in the evaluation of intrathoracic lymphatic extension of non-small cell bronchial cancer. A preliminary study of 30 patients].
Bury T; Corhay JL; Paulus P; Weber T; D'Harcour JB; Limet R; Rigo P; Radermecker MF
Rev Mal Respir; 1996 Jul; 13(3):281-6. PubMed ID: 8765921
[TBL] [Abstract][Full Text] [Related]
13. [Non-small cell lung cancer: evaluation of node and metastatic staging].
Brauner M; Brillet PY
Rev Pneumol Clin; 2008 Oct; 64(5):245-9. PubMed ID: 18995154
[No Abstract] [Full Text] [Related]
14. F-18 fluorodeoxyglucose positron emission tomography in the non-invasive staging of non-small cell lung cancer.
Berlangieri SU; Scott AM; Knight SR; Fitt GJ; Hennessy OF; Tochon-Danguy HJ; Clarke CP; McKay WJ
Eur J Cardiothorac Surg; 1999 Sep; 16 Suppl 1():S25-30. PubMed ID: 10536941
[TBL] [Abstract][Full Text] [Related]
15. Recommendations for optimal use of imaging studies to clinically stage mediastinal lymph nodes in non-small-cell lung cancer patients.
Whitson BA; Groth SS; Maddaus MA
Lung Cancer; 2008 Aug; 61(2):177-85. PubMed ID: 18280614
[TBL] [Abstract][Full Text] [Related]
16. Diagnostics and staging procedures in non-small cell lung cancer - is less more?
Heigener DF; Diemel KD; Reck M; Gatzemeier U
Clin Respir J; 2008 Apr; 2(2):67-73. PubMed ID: 20298309
[TBL] [Abstract][Full Text] [Related]
17. Accuracy and cost-effectiveness of [18F]-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer.
Kelly RF; Tran T; Holmstrom A; Murar J; Segurola RJ
Chest; 2004 Apr; 125(4):1413-23. PubMed ID: 15078754
[TBL] [Abstract][Full Text] [Related]
18. Lymph node staging in non-small cell lung cancer: evaluation by [18F]FDG positron emission tomography (PET).
Guhlmann A; Storck M; Kotzerke J; Moog F; Sunder-Plassmann L; Reske SN
Thorax; 1997 May; 52(5):438-41. PubMed ID: 9176535
[TBL] [Abstract][Full Text] [Related]
19. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography.
Lardinois D; Weder W; Hany TF; Kamel EM; Korom S; Seifert B; von Schulthess GK; Steinert HC
N Engl J Med; 2003 Jun; 348(25):2500-7. PubMed ID: 12815135
[TBL] [Abstract][Full Text] [Related]
20. Comparative efficacy of positron emission tomography with FDG and computed tomographic scanning in preoperative staging of non-small cell lung cancer.
Gupta NC; Graeber GM; Rogers JS; Bishop HA
Ann Surg; 1999 Feb; 229(2):286-91. PubMed ID: 10024112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]